PlexBio Co., Ltd.
TWO: 6572.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Ting Cao
- Headquarters
- Taipei, Taiwan
- IPO year
- 2016
- Market cap
- NT$1.1B
- Website
- https://www.plexbio.com
Loading 6572…
Loading profile data…Frequently asked questions about 6572
What does PlexBio Co., Ltd. (6572.TWO) do?
PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation extraction kits; IntelliPlex platform that is designed for pCode technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and m...
Where does 6572.TWO trade?
PlexBio Co., Ltd. (6572.TWO) trades on the Taipei Exchange.
What sector is 6572.TWO in?
PlexBio Co., Ltd. (6572.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of PlexBio Co., Ltd.?
Ting Cao is the chief executive officer of PlexBio Co., Ltd. (6572.TWO).
Where is PlexBio Co., Ltd. headquartered?
PlexBio Co., Ltd. is headquartered in Taiwan.
Does 6572.TWO pay a dividend?
PlexBio Co., Ltd. (6572.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6572.TWO go public?
PlexBio Co., Ltd. (6572.TWO) completed its initial public offering in 2016.